HTL8

HTL Biotechnology Invests €15 Million in HTL8 Polynucleotide Unit
The French biotech company expanded its Javené site with a new facility dedicated to pharmaceutical-grade polynucleotides.

The French biotech company expanded its Javené site with a new facility dedicated to pharmaceutical-grade polynucleotides.
We use cookies to measure readership and, with your permission, to show relevant TechUpscale ads on other sites. We honor Global Privacy Control. You can change your choice any time under "Cookie settings" at the bottom of every page. Privacy policy